Lyka Labs secures Indian patent for Pregabalin Gel 8%
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
The portfolio includes branded injectable cephalosporines for infectious diseases
The company expects to launch this product through its marketing partner in the near future
PRX-PLUS has a unique product feature with its deep-impacting formula
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
USFDA inspection at Emcure Pharmaceuticals API facility
Subscribe To Our Newsletter & Stay Updated